Journal of Dermatological Treatment

Papers
(The H4-Index of Journal of Dermatological Treatment is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Skin type classifications: does the perfect assessment exist?84
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Pso77
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Regist62
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)55
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa50
Lessons from a decentralized trial in atopic dermatitis: promises and perils42
A CollaboraTive Initiative of worldwide Vitiligo Experts and patients to define vitiligo activity (ACTIVE): study protocol39
The hf-PGA is a valid and reliable measure of hand/foot psoriasis severity in adults: results from a phase 2b clinical trial38
Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis37
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks33
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial30
Topical delgocitinib for the treatment of chronic hand eczema29
On-label persistence in psoriasis after switching to guselkumab, tumor necrosis factor inhibitors, interleukin-17 inhibitors, or apremilast from other advanced therapies28
A systematic review of recent randomized controlled trials for palmoplantar pustulosis28
Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits28
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy28
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab27
Correction27
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants26
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most25
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry24
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis24
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)24
Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients24
0.11923408508301